$30.12
al cierre: Nov 19, 4:00 PM EST
$30.12
N/A
Premercado: 3:00 AM EST
Viridian Therapeutics (VRDN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $-0.81 | $-1.02 | 20.6 % |
| Q2 | Aug 6, 2026 | $-1.05 | $-1.02 | -2.94 % |
| Q1 | May 5, 2026 | $-0.90 | $-1.07 | 15.9 % |
| Q4 | Feb 26, 2026 | $-1.08 | $-0.96 | -12.5 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 4, 2026 | $25.75K | $4.93M | -99.5 % |
| Q2 | Aug 6, 2026 | $233.00K | $22.00K | 959.1 % |
| Q1 | May 5, 2026 | $141.00K | $27.75K | 408.1 % |
| Q4 | Feb 26, 2026 | $132.00K | $16.84M | -99.2 % |
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-1.02 | $-1.02 | $-1.07 | $-0.96 |
| Actual | $-0.81 | $-1.05 | $-0.90 | $-1.08 |
| Surprise | +20.6% | -2.94% | +15.9% | -12.5% |
| Revenue | ||||
| Estimate | $4.9M | $22000 | $27750 | $16.8M |
| Actual | $25752 | $233000 | $141000 | $132000 |
| Surprise | -99.5% | +959.1% | +408.1% | -99.2% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.74 | $-0.69 | $-0.58 | $-0.50 |
| Revenue | ||||
| Consensus | $50.5M | $72.4M | — | — |
